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We describe a phage display technique that allows the pro-
duction and selective enrichment of phages that display an
N-glycoprotein (glycophages). We applied glycophage dis-
play to select functional glycosylation sequons from a pool
of randomized acceptor sequences. Our system provides a
genetic platform to study and engineer different steps in the
pathway of bacterial N-linked protein glycosylation.
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Introduction
Asparagine-linked (N-linked) protein glycosylation, the most
frequent posttranslational modiﬁcation of secretory proteins
in eukaryotic cells, was described to occur also in archaea
(Yurist-Doutsch et al. 2008) and in the ε-proteobacterium Cam-
pylobacter jejuni (Szymanski et al. 1999). In the latter case, it
was possible to transfer the glycosylation machinery that is en-
coded by a single locus, pgl, into Escherichia coli, resulting in
glycosylation-competent E. coli cells (Wacker et al. 2002).
This transfer into a genetically tractable system made it possi-
ble to study the basic mechanisms of bacterial N-linked protein
glycosylation in a deﬁned system (Feldman et al. 2005; Alaimo
et al. 2006; Kowarik et al. 2006) and opens the possibility to
apply advanced genetic tools, such as phage display, to study
this pathway. The M13 phage display is a widely used in vitro
selection technique that allows enrichment of proteins with de-
sired binding speciﬁcity or catalytic activities from complex
libraries (Smith and Petrenko 1997; Forrer et al. 1999; Tanaka
et al. 2005). Phage display systems are based on genetic fu-
sions of proteins or peptides to phage coat proteins. The
fusion proteins are secreted to the periplasm (Steiner et al.
2006), where they stay membrane associated until they are in-
corporated into the progeny phage particle. Packaging of the
fusion-encoding phagemid into the phage particles establishes
a physical link between the phenotype of the displayed protein
and the corresponding genotype. Recently, the scope of phage
display was extended towards the display of posttranslational
modiﬁcations, such as phosphorylation and phosphopantethei-
nylation (Yen and Yin 2007), and of proteins with reactive,
unnatural amino acids that allow for subsequent site-speciﬁc
conjugation with non-peptide ligands (Tian et al. 2004). We
describe the combination of a phage display system with the
process of N-linked protein glycosylation.
Results
To establish a novel genetic system of N-glycosylation in E.
coli, we took advantage of the periplasmic co-localization of
this protein modiﬁcation and phage assembly to produce phage
populations that expose an N-linked glycan on their surface
(glycophages). The phenotypic display of N-linked glycans
can be physically linked to any of the genes encoding compo-
nents of the N-glycan biosynthetic pathway by locating the
gene of interest on the phagemid (Figure 1).
In our initial setup, we constructed phagemid pHEN1(AcrA-
P3) expressing the model glycoprotein AcrA of C. jejuni lack-
ing the N-terminal lipid anchor sequence as a C-terminal
fusion with the minor phage coat protein P3 (AcrA-P3). The
pectate lyase B signal sequence (pelB) upstream of the acrA
coding sequence ensured Sec-dependent translocation of the
fusion protein. AcrA is glycosylated at asparagine residues
N123 and N273 that are included within the bacterial consensus
sequence D/E–X1–N–X2–S/T (X1,2≠P) (Kowarik et al. 2006).
Non-glycosylatable AcrA(N123L, N273L)-P3 was expressed
from phagemid pHEN1(AcrA*-P3) and served as a control.
As expression host, we employed E. coli TG1 cells containing
either plasmid pACYCKan(pgl) or pACYCKan(pglmut). Both
constructs encode the complete operon for N-linked protein gly-
cosylation from C. jejuni, the latter with a dysfunctional
oligosaccharyltransferase PglB (Wacker et al. 2002). Superin-
fection of these cells with VCS M13 helper phage resulted in
the packaging of the pHEN1 phagemids into progeny phage
particles. Recombinant phage titers of ~1011 infective units
per milliliter of culture supernatant were obtained. Sodium do-
decyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
separation of cell-free total phage protein followed by immuno-
blot analysis identiﬁed a protein that was cross-reactive against
both P3 antibody and anti-AcrA antiserum and migrated as a
protein of ~120 kDa molecular mass, corresponding to the ex-
pected mobility of AcrA-P3 (Figure 2). The lack of this protein
in the culture supernatant from non-infected cells demonstrated
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Fig. 1. The glycophage display system. Plasmids/phagemids encoding the enzymes for N-linked protein glycosylation (pACYCKan(pgl)) and for the acceptor
AcrA-P3 fusion protein (pHEN1(AcrA-P3)) are shown. Catalyzed by individual glycosyltransferases, the oligosaccharide is assembled on a lipid carrier,
bactoprenylpyrophosphate, at the cytoplasmic side (CP) of the inner membrane. The lipid-linked glycan is translocated by the ﬂippase PglK across the inner
membrane (IM) to the periplasmic space (PS) where the glycan is transferred to speciﬁc asparagine residues (N) of the acceptor protein AcrA-P3 by the
oligosaccharyltransferase PglB. After infection with helper phage VCS M13, secreted phage particles that display the glycosylated acceptor protein (glycophages)
are bound to glycan-reactive, biotinylated IgG, and the resulting immunocomplex is captured with streptavidin-coated beads. Glycophages are ﬁnally eluted
and used to re-infect E. coli (F+) cells. In general, the glyco-phenotype of the phage can be connected to the genotype for any enzyme required for bacterial,
N-linked protein glycosylation (kan, kanamycin resistance gene; bla, gene encoding beta-lactamase).
Fig. 2. Immunoblot analyses of phage samples. Phages produced from glycosylation-competent E. coli TG1 (pgl) cells, harboring either phagemid pHEN1
(AcrA-P3) or pHEN1(AcrA*-P3), and from non-glycosylation-competent E. coli TG1 (pglmut) cells, harboring phagemid pHEN1(AcrA-P3), were separated by
SDS-PAGE. Phages were collected by PEG precipitation of cell-free culture supernatants, and sample amounts were normalized to OD268. The signal intensity of
the P3 wild-type protein at ~60 kDa reﬂects equivalent amounts of phage protein per sample. P3, AcrA-P3, AcrA*-P3, and glycosylated AcrA-P3 were visualized
with monoclonal anti-P3 antibody, polyclonal AcrA-, and glycan-speciﬁc antiserum HR6.
The Escherichia coli glycophage display system
phage-dependent secretion to medium. To detect glycosylated
AcrA-P3, the same phage samples were probed with glycosyla-
tion-speciﬁc HR6 antiserum that had been raised against E. coli
membranes displaying the C. jejuni glycan (S. Amber and M.
Aebi, manuscript in preparation). Here, an immunoreactive pro-
tein with amass of ~120 kDawas detected in phage samples that
were derived fromTG1(pgl, AcrA-P3) cells. In contrast, this sig-
nal was absent when either TG1(pgl, AcrA*-P3) or TG1(pglmut,
AcrA-P3) cells were used for phage preparation. These results
demonstrated that fusion proteins AcrA-P3 and the AcrA*-P3
were both translocated to the periplasm of E. coli TG1 and that
only the former was glycosylated by the enzymatic machinery
encoded by the C. jejuni pgl operon.
To make use of the display of glycosylated AcrA-P3, we de-
veloped a panning strategy that allowed selective enrichment
of glycophages. We isolated and biotinylated the IgG fraction
from the anti-glycan reactive HR6 antiserum and mixed it with
glycophage containing phage preparations. The resulting IgG/
glycophage immunocomplex was captured with streptavidin-
coated beads. Bound phages were eluted by a shift to basic
conditions (pH 12). To determine the eﬃciency of this panning
method, we aimed to enrich glycophages from excess back-
ground of phages displaying non-glycosylated AcrA*-P3.
Glycosylation-competent E. coli TG1 (pgl) cells expressing ei-
ther glycosylatable AcrA-P3 or non-glycosylatable AcrA*-P3
were mixed in ratios from 1:103 to 1:106. After superinfection
of the mixed cultures with helper phage progeny, phage sam-
ples were prepared and subjected to the HR6-IgG panning
procedure. Eluates containing enriched phage populations were
used to re-infect glycosylation-competent E. coli TG1 (pgl)
cells. Pooled re-infectants were used for additional HR6-IgG
panning cycles. In addition, these phage preparations were ex-
amined by immunoblot analysis to identify glycosylated
AcrA-P3. Phage samples that were produced from cultures
with a 103-, 105-, and 106-fold excess of cells expressing
non-glycosylatable AcrA*-P3 showed a HR6 reactive signal
for glycosylated AcrA-P3 after one, two and three rounds of
enrichment, respectively (Supplementary Figure 1), conﬁr-
ming selective enrichment of glycosylatable phagemid. To
measure the enrichment of the glycophage-associated genotype,
the relative increase of re-infectants containing phagemid
pHEN1(AcrA-P3) was monitored after each panning cycle by
polymerase chain reaction (PCR) (Table 1 and Materials and
methods section). Phagemid pHEN1(AcrA-P3) was enriched
up to 100-fold per round of panning. Consequently, three
and four cycles of our panning method were suﬃcient to con-
vert mixed populations with a 105- and 106-fold excess of
non-glycophage-producing cells into almost homogenous po-
pulations of glycophage-producing cells, respectively (Table 1
and Supplementary Figure 1).
To evaluate the potential of the glycophage system for the se-
lection of glycosylation-speciﬁc genetic traits, we investigated
the sequence requirements of a bacterial N-glycosylation site
as a proof of principle. The bacterial N-glycosylation requires
a glutamate or aspartate residue at the −2 position relative to
the asparagine in the consensus sequence N–X–S/T(Kowarik
et al. 2006). We created a library of AcrA(N123, N273L)-P3
in which the residues at positions −2, −1, and +1 relative to
the single glycosylation site N123 of this AcrAvariant were ran-
domized, N123 was kept constant, and only serine or threonine
residues were allowed at position +2. The corresponding mu-
tations were introduced into pHEN1(AcrA*-P3) by PCR using
degenerated oligonucleotides. The library with a theoretical
complexity of 1.6 × 104 AcrA variants consisted of about
1.5 × 105 independent clones and thus essentially covered
the theoretical sequence space. The complexity of the library
was veriﬁed by DNA sequence analysis to ensure the random
distribution of all four nucleotides for the codon triplet at po-
sitions −2, −1, and +1 of the glycosylation site, while A or T
varied at the ﬁrst position of the triplet codon for the +2 po-
sition (corresponding to S or T). Three panning rounds were
carried out with phages displaying the degenerate AcrA-P3 li-
brary. Phagemids from single colonies obtained after infection
of E. coli TG1(pACYC(pgl)) cells with the eluates after each
panning round were assessed by DNA sequencing. The de-
duced amino acid sequences of the randomized AcrA-P3
segments from clones encoding full-length AcrA-P3 variants
are listed in Table 2. Within this phagemid population, the
proportion of variants encoding an aspartate (D) or a gluta-
mate (E) at position −2 relative to N123 was continuously
increased during the course of the panning procedure, in
agreement with the previously described requirement of the
D/E–X1–N–X2–S/T sequence for N-glycosylation in this bac-
terial system(Kowarik et al. 2006). Further analyses of the
amino acid distribution at the −2 and +2 positions showed
that aspartate was favored over glutamate and serine favored
over threonine, respectively. A slight preference for hydropho-
bic residues could be observed at positions +1 or −1 but
without enrichment of speciﬁc hydrophobic amino acids.
Discussion
We extended the analysis of the established phage display
technology towards the posttranslational process of N-linked
protein glycosylation. The glycophages displayed the hepta-
oligosaccharide of C. jejuni, which is also produced in E. coli.
Using glycan-speciﬁc HR6 antibodies, we developed a high-
aﬃnity selection procedure and showed that glycophages were
still infective towards the E. coli F+ strain TG1 after elution. The
enrichment of glycophages was possible from mixed cell cul-
tures where 103 glycophage-producing cells were mixed with
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Table 1. Glycophage enrichment
E. coli TG1 (pgl) cells
(OD600 equivalents)
Enrichment of the glyco-genotype
(pHEN1(AcrA-P3)) after the indicated
round of HR6-IgG panning (clones
with glycosylation-competent genotype/
number of analyzed clones)
AcrA-P3 AcrA*-P3
(N123L, N273L)
1st 2nd 3rd 4th
10−3 1 6/16 15/16 – –
10−5 1 0/14 11/32 16/16 –
10−6 1 – 0/16 2/23 22/23
Glycosylation-competent E. coli TG1 (pgl) cells expressing either glycosyla-
table AcrA-P3 or non-glycosylatable AcrA*-P3 were mixed at the indicated
ratios. After infecting the mixed cell cultures with VCS M13, progeny phages
were prepared and applied to multiple rounds of the HR6-IgG-biotin panning.
Phages containing eluates obtained after each panning cycle were used to
re-infect E. coli TG1 (pgl) cells. Ampicillin-resistant re-infectants were then
screened (see Materials and methods section) to determine the proportion of
clones containing the glycosylation-competent pHEN1(AcrA-P3) phagemid.
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106 non-glycophage-producing cells prior to infection with
helper phage. In contrast to classical phagemid-based display
systems where the number of recoverable phages depends
mainly on the level of protein display, with typically 1% to
10% of recombinant phages displaying the phagemid encoded
protein (Clackson and Lowman 2004), the formation of gly-
cophages additionally requires enzymatic modiﬁcation of the
fusion protein prior to its incorporation into phage particles.
Both eﬀects, incomplete glycosylation and disfavored incor-
poration of the fusion protein, considerably reduced the
fraction of recoverable phages. As less than 0.1% of the
phages produced from infected TG1(pgl, AcrA-P3) cells were
glycophages, our data reveal glycophage enrichment from an
at least 109-fold excess of non-glycophages produced from a
mixed cell culture.
The identiﬁcation of the speciﬁc requirements for bacterialN-
glycosylation using the glycophage display system in an accep-
tor site screen presents a proof of concept. However, it is
important to note that the enrichment of clones with functional
glycosylation sites was partly masked by the accumulation of
clones containing a stop codon, a frame shift, or a deletion up-
stream of the g3p genewhich consequently abolished translation
and display of the fusion protein. The enrichment of such clones
was most likely favored at two levels during the selection pro-
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Table 2. Enrichment of functional glycosylation sites
Randomly selected clones 
AcrA(X-X-N123-X-S/T)-P3 
Randomly selected clones from enriched pools after the indicated round of HR6-IgG panning
 
1st 2nd 3rd 
VLNCS TSNSS ELNLS DNNTS 
RWNWT TANNT NPNFT DLNMS 
MLNTS GFNGT IVNIT DCNKS 
LYNGS RYNFS DDNVS DNNRS 
AINLS SSNQS EVNDS DHNMS 
NANTS MGNRT ENNAS DINSS 
LNNTS QLNLT EGNRS DYNVS 
SHNIT AGNRS 
 
DINSS 
ANNQT IHNDS 
 
DFNLT 
YSNRT EVNVT 
 
DDNVS 
GGNFS GGNMS  
 
DFNLT 
 
GLNCS  
 
IKNKS 
   
DLNVT 
   
ENNAS 
   
EVNSS 
   
DANVS 
   
DLNVT 
   
DGNPS 
   
TDNIT 
   
ARNVS 
   
ETNAT 
   
DTNTS 
   
ECNLS 
Ntotal=14 
NΔ= 3 
Ntotal=17 
NΔ= 5 
NΔ/Ntotal=0.29
Ntotal=27 
NΔ= 20 
NΔ/Ntotal=0.74
Ntotal=59
NΔ=36
NΔ/Ntotal=0.61NΔ/Ntotal=0.21 
from initial library pool  
Pentapeptide sequences surrounding the randomized AcrA glycosylation site N123 were obtained before and after several rounds of enrichment. The sequences of
library variants encoding a full-length fusion protein are shown. Sequences representing the canonical glycosylation site motif for bacterial N-linked glycosylation
are highlighted in gray. Ntotal, number of analyzed clones, NΔ, number of clones containing a stop codon, a frame shift, or a deletion.
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cess. Firstly, the corresponding cells are not impaired by the ex-
pression of the potentially inhibitory heterologous fusion
protein, and secondly, the phages produced from such clones
have a wild-type phenotype and thus confer their genetic infor-
mation much more eﬃciently than those displaying a bulky
fusion protein during re-infection. The enrichment of phagemids
that did not express the fusion protein occurred only when we
used a randomized phage library; such phagemids were not ob-
served in our reconstitution experiments using phages that
express either glycosylatable or non-glycosylatable AcrA-P3 fu-
sion protein. We postulate that such phages were generated in
the course of the library preparation.
The glyco-epitope used in our experimental setup is the
product of a biosynthetic pathway that requires multiple compo-
nents: cytoplasmic glycosyltransferases of the oligosaccharide
biosynthetic pathway, the lipid-linked oligosaccharide ﬂippase,
the oligosaccharyltransferase, and the acceptor protein. The
glyco-phenotype of the phage can therefore be directly linked
to the genotype of any of the steps required for the synthesis of
the glyco-epitope displayed on the surface of the ﬁlamentous
phage M13 (Figure 1), and it can be used for the functional
screening of variations in each of these steps. The glycophage
screening system might therefore be exploited for the identiﬁ-
cation of novel oligosaccharyltransferases and ﬂippases, the
identiﬁcation of new acceptor peptides, or the identiﬁcation
of novel glycosyltransferases involved in the assembly of lip-
id-linked oligosaccharides. In the latter case, the enrichment
strategy needs to be modiﬁed to allow for the selection of
the target glycan structure, e.g., by using speciﬁc lectins or
antibodies. These screening procedures are possible due to
the relaxed lipid-linked oligosaccharide speciﬁcity of the key
elements in the N-glycosylation pathway, the lipid-linked oli-
gosaccharide ﬂippase PglK(Alaimo et al. 2006), and the
oligosaccharyltransferase PglB(Feldman et al. 2005). In addi-
tion, in vitro evolution strategies to ﬁnd pathway components
with altered properties will now be possible.
Materials and methods
Strains and material
E. coli XL1-Blue (Stratagene) was used for cloning and E. coli
TG1 (Stratagene) for production and titer determination of
M13 phages. VCS M13 (Stratagene) was used as helper phage
and propagated as described (Clackson and Lowman 2004).
Phagemid constructions
Molecular genetics methods were performed according to
standard protocols (Sambrook and Russell 2001). To express
wild-type AcrA fused to the minor phage coat protein P3, an
acrA-containing PCR fragment was ampliﬁed from plasmid
para(AcrA-P3) (Table 3; Supplementary information) and in-
serted into NcoI–NotI cut phagemid pHEN1 (Hoogenboom et
al. 1991). The phagemid backbone pHEN1 has the M13 ori to
allow the phagemid to be packaged into the phage particles and
encodes ampicillin resistance for selection. Primers NcoI_fw
(5′-AGCCGGCGATGGCCATGGATATTGGAATTAATTCG-
3′) and NotI_rv (5′-TGTCGTCGTTGGCGGCCGCTTGTGC-
TCCAATTTC-3′, the NcoI and the NotI restriction sites are
underlined, respectively) were used for ampliﬁcation from
template vector para(AcrA-P3) (Supplementary information).
On the resulting phagemid pHEN1(AcrA-P3), the gene for
the fusion protein is transcribed under control of the lacZ pro-
moter/operator and expressed with the N-terminal peptide
leader sequence pelB to direct Sec-dependent translocation to
the periplasm. A phagemid encoding non-glycosylatable AcrA
(N123L, N273L)-P3 was constructed by replacing the NcoI-
EagI fragment of phagemid pHEN1(AcrA-P3) with the NcoI-
EagI fragment of phagemid para(AcrA(N123L, N273L)-P3)
(Supplementary information) resulting in pHEN1( AcrA*-P3).
To randomize the positions −2, −1, and +1 and to allow a se-
rine or threonine insertion at position +2 of the AcrAwild-type
glycosylation sequon N123, a 783-bp PCR fragment was created
with primers NF_1 ( 5′-TAACTTTCGAAAATGCAAG-
CAAGNNNNNNAAYNNNWCTAAAGCTCTTTTTAGC-3′)
and AcrA_pHEN_2 (5′-AATCGTCATCTGCGGCCGCTT-
GTGCTCCAATTTCTTTAACTTCG-3′, the Bsp119I and the
Eco52I restriction sites are underlined, respectively) using pha-
gemid pHEN1(AcrA(N123L, N273L)-P3) as template. The PCR
product was used to replace the Bsp119I-Eco52I fragment from
phagemid pHEN1(AcrA(N123L, N273L)-P3), resulting in the
phagemid library pHEN1(AcrA(X-X-N123X-S/T)-P3).
Production of phages displaying glycosylated AcrA
(glycophages)
2xTY medium containing 1% glucose, 100 μg/mL ampicillin,
and 35 μg/mL kanamycin were inoculated with a single colony
of E. coli TG1 harboring the phagemid pHEN1(AcrA-P3) and
the pgl operon encoded by plasmid pACYC(pgl) and grown
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Table 3. Plasmids used in this study
Plasmid Relevant characteristics Source or reference
pHEN1 Phagemid with the M13 origin of replication, NcoI/NotI cloned inserts are expressed as
N-terminal fusions with the P3 phage coat protein with a pelB leader sequence for
translocation. Expression is controlled by the lacZ promoter, AmpR
(Hoogenboom et al. 1991)
pACYCKan(pgl) Encodes the C. jejuni pgl cluster, KanR This work
pACYCKan(pglmut) Encodes the C. jejuni pgl cluster containing mutations W458A and D459A in PglB, Kan
R This work
pHEN1(AcrA-P3) Phagemid expressing glycosylatable AcrA-P3 fusion protein under the control of the lac
promoter with pelB leader sequence, AmpR
This work
pHEN1(AcrA*-P3) Phagemid expressing non-glycosylatable AcrA(N123L, N273L)-P3 fusion protein under
the control of the lac promoter with pelB leader sequence, AmpR
This work
para(AcrA-P3) Phagemid expressing AcrA-P3 fusion protein under the control of pBAD promoter
with pelB leader sequence, AmpR
This work (Supplementary
information)
para(AcrA(N123L,N273L)-P3) Phagemid expressing AcrA (N123L, N273L)-P3 fusion protein under the control of
pBAD promoter with pelB leader sequence, Amp
R
This work (Supplementary
information)
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overnight at 37°C with shaking at 190 rpm. Fresh 2xTY me-
dium (25 mL) containing 1% glucose, 100 μg/mL ampicillin,
and 35 μg/mL kanamycin was inoculated with the overnight
culture to OD600 of 0.1 and grown at 37°C with shaking at
190 rpm. Cells were superinfected with a helper phage prep-
aration at OD600 of 0.5 at a multiplicity of infection of ~20,
and the cultures were incubated for 40 min at 37°C without
shaking. The medium was changed by harvesting the cells
by centrifugation (3000 × g, 4°C, 10 min), and the cell pellet
was resuspended in 50 mL 2xTY medium containing 100 μg/
mL ampicillin and 35 μg/mL kanamycin. The cultures were
grown overnight at 30°C with shaking at 190 rpm. After growth
for 16 to 20 h, the culture supernatant was separated from the
cells by centrifugation (3000 × g, 4°C, 30 min) and incubated
on ice for 1 h after addition of a solution of ice-cold 20%
polyethyleneglycol (PEG, Fluka)—2.5 M NaCl to one-ﬁfth
of the ﬁnal volume. The precipitated phage particles were col-
lected by centrifugation (3000 × g, 4°C, 30 min) and
dissolved in 1 mL of water. To remove any HR6-reactive rem-
nants from the phage surface, the phage particles were further
puriﬁed by treatment with 1% Triton X-100 at room temper-
ature (RT) for 30 min on a turning wheel (60 U/min). Phages
were again PEG precipitated, redissolved in 1 mL phosphate-
buﬀered saline (PBS), and further incubated with 2% sarkosyl
at RT for 30 min on a turning wheel. After a ﬁnal PEG-
precipitation, phages were dissolved in 1 mL PBS containing
10% glycerol and a protease inhibitor cocktail (Complete,
EDTA-free, Roche Diagnostics). The total concentration of
phage particles was estimated spectrophotometrically at OD268
(with OD268 = 1.0 corresponding to 5*10
12 colony forming
units per milliliter (Clackson and Lowman 2004)). Phage
titers were determined by infecting 0.9 mL of exponential
phase E. coli TG1 cells with 100 μL of a 104-fold dilution
of the phage preparation followed by incubation for 40 min
at 37°C without shaking. One hundred microliters of a 102-
and a 104-fold dilution of the infection sample were spread
on 2xTY plates containing 1% glucose and 100 μg/mL ampi-
cillin. The plates were incubated for 16 h at 37°C, and the
plaques were counted.
Cell mixing experiment
To determine the minimal fraction of glycophage-producing
cells that still allowed the trapping of glycophages by the
HR6-IgG panning, glycophage-producing E. coli TG1
(pHEN1(AcrA-P3), pACYC(pgl)) cells were mixed with 103-,
105-, and 106-fold excesses of non-glycophage-producing E.
coli TG1 (pHEN1(AcrA*-P3), pACYC(pgl)) cells (based on
OD600 equivalents). Fresh 2xTY medium (25 mL) containing
1% glucose, 100 μg/mL ampicillin, and 35 μg/mL kanamycin
was inoculated with each of the cell mixtures to OD600 of 0.1
and grown at 37°C with shaking at 160 rpm. Progeny phages
were produced by superinfecting mixed cell populations with
helper phage (as described above) and glycophages enriched
by the HR6-IgG panning (see below).
Enrichment of glycophages
Approximately 1010 cfu of glycophage-containing phage pre-
parations were mixed with 5 mL PBS containing 4% milk,
0.1% Tween-20, and 1.5 μg/mL biotinylated HR6-IgG
(~6 mol biotin per mol IgG) and incubated for 1 h at RT on a
turning wheel (30 U/min). Streptavidin-coated beads (50 μL)
(binding capacity 2 mg/mL biotinylated BSA/mL; PIERCE)
were washed two times with 10 mL PBS and blocked with
10 mL PBS containing 4% milk and 0.1% Tween-20 for 30
min on a turning wheel at RT. The blocked beads were sedimen-
ted (3000 g, 2 min) and added to the phage/HR6-IgG sample to
capture the immunocomplex. After incubating the mixture for 1
h at RT, the beads were washed ﬁve times with 10 mL PBS con-
taining 0.1% Tween-20 and ﬁve times with 10 mL PBS (for
each washing step, beads were incubated 5 min at RTon turning
wheel and then sedimented). To elute adherent glycophages, the
beads were incubated with 1 mL of 100 mM triethylamine
(pH 12.0) and sedimented, and the supernatant was immedi-
ately neutralized with 500 μL 1 M Tris-HCl (pH 7.2). To
recover the phagemids from eluted phages for genotype deter-
mination, 0.1 mL of the neutralized eluate was used to infect
0.9 mL exponential-phase E. coli TG1 cells (as described
above). To repropagate the enriched phage population, 1 mL
of the neutralized eluate was used to infect 9 mL exponential-
phase E. coli TG1 cells harboring the plasmid pACYCKan(pgl).
The infected cells were harvested by centrifugation (2500 × g,
5 min), resuspended in 1 mL 2xTY medium, and spread on ﬁve
2xTYagar plates containing 1% glucose, 100 μg/mL ampicillin,
and 35 μg/mL kanamycin. After incubating the plates for 16 h at
37°C, all colonies were pooled and used to inoculate 25 mL
2xTY medium containing 1% glucose, 100 μg/mL ampicillin,
and 35 μg/mL kanamycin to OD600 of 0.1. Glycophages were
produced from this culture as described above und subjected
to further rounds of enrichment.
Genotype discrimination between phagemids
pHEN1(AcrA-P3) and pHEN1(AcrA*-P3)
Phagemid DNA of pHEN1(AcrA-P3) and pHEN1(AcrA*-P3)
can be discriminated by EcoRI digestion since the latter pha-
gemid contains an additional EcoRI site due to the N273L
mutation. To determine which phagemids were present in
an E. coli TG1 reinfectant, a 1443-bp fragment was ampliﬁed
using primer pair screen_fw (5′-AAGCGGAAGAGCGCC-
CAATACG-3′)/NotI_rv (sequence, see above) by colony
PCR, and the DNA was analyzed by gel electrophoresis after
EcoRI digestion. The EcoRI digested fragment ampliﬁed
from phagemids pHEN1(AcrA-P3) resolved into diagnostic
fragments of 368 and 1075 bp. In contrast, the fragments am-
pliﬁed from phagemid pHEN1(AcrA*-P3) resolved into
fragments of 774, 386, and 301 bp after EcoRI digest.
Preparation of biotinylated HR6-IgG
Raw serum (rabbit) (500 μL) was diluted with 10 mL binding
buﬀer (20 mM sodium phosphate, pH 7) and ﬁltrated through a
membrane with 0.22 μm pore size. To isolate the IgG fraction,
the serum sample was subjected to protein G chromatography
(HiTrap, GE Helthcare) according to the manufacturer's proto-
col. IgG containing eluates were analyzed by SDS-PAGE, and
fractions containing pure IgG were combined. The pooled frac-
tions were buﬀer exchanged to PBS using a PD-10 desalting
column and used for in vitro biotinylation with Sulfo-NHS-
LC-Biotin reagent (PIERCE) according to the manufacturer's
protocol. The biotinylated HR6-IgG sample was again desalted
using a PD-10 desalting column, and the ﬁnal IgG concentra-
tion was adjusted to 0.5 mg/mL.
1371
The Escherichia coli glycophage display system
Phage immunoblots
Approximately 4 × 1010 puriﬁed phage particles per lane were
applied to a 10% SDS-PAGE under reducing conditions, and
the protein bands were subsequently electroblotted on a nitro-
cellulose membrane (Protran membrane, Whatman). The
membranes were blocked for 1 h at RT in PBS containing
10% milk and 0.1% Tween-20. As primary antibody, either
mouse anti-P3 (New England Biolab), rabbit anti-AcrA1, or
rabbit HR6 antiserum (S. Amber and M. Aebi, manuscript in
preparation) was used in PBS containing 5% milk and 0.1%
Tween-20 (1 h at RT). As secondary antibody, either a goat
anti-mouse or goat anti-rabbit IgG horseradish peroxidase con-
jugate (Santa Cruz) was used in PBS containing 5% milk and
0.1% Tween-20 (1 h at RT). The horseradish peroxidase reac-
tivity was detected with ECL reagent (GE Healthcare).
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